Publications

5674 Results

Chemohormonal therapy in premenopausal node-positive, receptor-positive breast cancer: an Eastern Cooperative Oncology Group phase III intergroup trial (E5188, INT-0101).

Authors
NE Davidson;A O'Neill;A Vukov;CK Osborne;S Martino;D White;M Abeloff
Journal / Conference
Proc of the American Society of Clinical Oncology 22:5(#15)
Year
2003
Research Committee(s)
Breast
Study Number(s)
SWOG-8851 (INT-0101) (EST-5188)

EGFR, HER2 and ERB-B pathway activation in bronchioloalveolar carcinoma (BAC): analysis of SWOG 9417 and lung spore tissue samples.

Authors
WA Franklin;PH Gumerlock;J Crowley;K Chansky;HJ West;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology 22:620(#2493)
Year
2003
Research Committee(s)
Lung
Study Number(s)
S9714

Phase II trial of gemcitabine as first line chemotherapy in patients with metastatic or unresectable soft tissue sarcomas (STS).

Authors
GV Burton;C Rankin;LE Flaherty;EC Borden;GM Mills;K Antman
Journal / Conference
Proc of the American Society of Clinical Oncology 22:820(#3297)
Year
2003
Research Committee(s)
Sarcoma
Study Number(s)
S9802

Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an Intergroup trial

Authors
DB Duggan;GR Petroni;JL Johnson;JH Glick;RI Fisher;JM Connors;GP Canellos;BA Peterson
Journal / Conference
Journal of Clinical Oncology 21(4):607-614
Year
2003
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8952 (INT-0111) (CALGB-8952) (EST-5489)

Application of imaging approaches to the monitoring of immune-based therapies for breast cancer

Authors
B Almond;RM Ahlquist;DA Mankoff;ML Disis;KL Knutson
Journal / Conference
Proc of the American Association for Cancer Research 44:#3807
Year
2003

Correlation of computerized tomography (CT) and proton emission tomography (PET) in patients with metastatic GIST treated at a single institution with imatinib mesylate

Authors
H Choi;C Charnsangavej;HA Macapinlac;MA Burgess;SR Patel;LL Chen;DA Podoloff;RS Benjamin
Journal / Conference
Proc of the American Society of Clinical Oncology 22:819(#3290)
Year
2003
Research Committee(s)
Sarcoma
Study Number(s)
S0033

Prognostic significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukaemia

Authors
ED Hsi;KJ Kopecky;FR Appelbaum;DH Boldt;T Frey;M Loftus;MA Hussein
Journal / Conference
British Journal of Haematology 120:1017-1025
Year
2003
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9108 (CALGB-9011), S9706

Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a Southwest Oncology Group and Gynecologic Oncology Group trial

Authors
M Markman;PY Liu;S Wilczynski;B Monk;LJ Copeland;RD Alvarez;C Jiang;D Alberts
Journal / Conference
Journal of Clinical Oncology 21(13):2460-2465
Year
2003
Research Committee(s)
Gynecologic
Study Number(s)
S9701

The prostate cancer prevention trial: design, status, and promise

Authors
IM Thompson;C Tangen;P Goodman
Journal / Conference
World Journal of Urology 21:28-30
Year
2003
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Ten-year survival in patients with metastatic prostate cancer

Authors
CM Tangen;J Faulkner;ED Crawford;IM Thompson;D Hirano;M Eisenberger;M Hussain
Journal / Conference
Clinical Prostate Cancer 2(1):41-45
Year
2003
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8894 (INT-0105) (EST-2889)